ALB · 8-K · 20260805PR000101
Portfolio Reshaping (M&A / Divestiture)
ALBEMARLE CORP · 2026-08-05 · Importance 59 · Surprise 60 · In source text
Albemarle sold a controlling stake in its Ketjen refining catalyst solutions business on March 2, 2026, and subsequently classifies the refining catalyst earnings as equity income within Corporate. The transaction also involved divesting the company’s full 50% ownership interest in the Eurecat joint venture. Albemarle recorded a $52.7 million net loss on these first-quarter transactions. Post-transaction adjusted EBITDA and equity-income contributions from the retained and divested catalyst businesses are expected to be immaterial.
Key facts
- Following the March 2, 2026 sale, refining catalyst business earnings are classified as equity income and expected adjusted EBITDA and equity income contributions from these are immaterial post transaction source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | realized | — | Following the March 2, 2026 sale, refining catalyst business earnings are classified as equity income and expected adjusted EBITDA and… |